type	study_id	dbgap_accession	study_name	study_acronym	study_description	consent	consent_number	external_url	experimental_strategy_and_data_subtype	study_status	study_period_start	study_period_stop	study_data_types	size_of_data_being_uploaded	crdc_id	id
study	phs000463	phs000463	TARGET: Acute Lymphoblastic Leukemia (ALL) Pilot Phase 1	TARGET_ALL_P1	There are 189 fully characterized patient cases that make up the pilot phase (Phase I) of the TARGET ALL dataset, each with gene expression, tumor and paired normal copy number analyses, and at least one type of sequencing (Sanger and/or next-generation) data available. There are 230 cases with partial molecular characterization and/or sequencing data available, to include whole genome sequencing, mRNA-seq and/or kinome sequencing.	DS-PEDCR	1	https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000463		Completed						3ac2526a-b2f8-597a-87f6-9d2d6c4c5364
